{"id":"433ae311-1cf0-498c-b141-485dd4038c3a","url":"https://www.sciencedaily.com/releases/2026/09/260917003732.htm","domain":"sciencedaily.com","outlet":{"name":"ScienceDaily","country":"US","cred":3,"lean":0,"curated":true},"title":"These blood thinners may have an unexpected benefit for Alzheimer’s patients","plainHeadline":"NOACs slow cognitive decline in Alzheimer’s patients with atrial fibrillation","rewrite":{"model":null,"at":null},"summary":["Karolinska Institutet study analyzed 7,308 patients with atrial fibrillation and Alzheimer’s.","Participants were grouped to NOACs, warfarin, or no anticoagulant treatment.","NOACs slowed MMSE decline by about 0.2 points per year versus others.","NOACs also linked to lower risks of death, stroke, clots, and fractures.","Study notes observational design and cannot prove causation; potential confounders exist."],"topics":["Health","Science","Education"],"lang":"eng","publishedAt":"2026-09-18T09:48:31.000Z","ingestedAt":"2026-09-18T10:51:41.660Z","story":"https://brief.concise.news/story/30525ca9-7815-447b-b045-f70096eb0e54","storyId":"30525ca9-7815-447b-b045-f70096eb0e54","image":"https://www.sciencedaily.com/images/1920/glowing-human-brain-signals.webp","author":null,"dek":"Newer blood thinners may do more than prevent strokes in people with Alzheimer’s disease and atrial fibrillation. Researchers found that patients taking NOACs experienced a slower decline in cognitive function than those using warfarin or no blood thinners."}